Related Experiment Videos
Excluded from universal coverage: ESRD patients not covered by Medicare
1Medical Technology and Practice Patterns Institute, Washington, DC 20007, USA.
Health Care Financing Review
|December 4, 1995
Summary
Medicaid is a key insurer for end-stage renal disease (ESRD) patients without Medicare. This study found significant differences in demographics and dialysis care between Medicaid and Medicare ESRD populations, highlighting considerable Medicaid spending.
Area of Science:
- Nephrology
- Health Services Research
- Public Health Policy
Background:
- Medicaid is a primary payer for end-stage renal disease (ESRD) patients ineligible for Medicare.
- Understanding the characteristics and costs of this population is crucial for healthcare policy.
Purpose of the Study:
- To compare demographics, dialysis services, and costs of Medicaid-only ESRD patients with Medicare ESRD populations.
- To analyze differences in patient characteristics and healthcare utilization between these two ESRD groups.
Main Methods:
- Comparative analysis of demographic data, dialysis service receipt, and healthcare costs.
- Examination of patient populations in California, Georgia, and Michigan.
- Focus on Medicaid-only ESRD patients versus Medicare ESRD patients.
Main Results:
- Observed notable differences in patient demographics between Medicaid and Medicare ESRD populations.
- Identified variations in dialysis practice patterns and inpatient resource utilization.
- Medicaid expenditures for Medicare-ineligible ESRD patients were substantial in 1991.
Conclusions:
- Significant disparities exist between Medicaid and Medicare ESRD patient populations.
- Medicaid bears considerable financial responsibility for ESRD patients lacking Medicare coverage.
- Findings underscore the importance of analyzing payer-specific data for ESRD patient management and policy development.